(Q44251909)

1 December 2017

title

Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test (English)

1 reference

1 December 2017

0 references

0 references

1 reference

6

Bernard Zinman

1 reference

1 December 2017

3

Anthony J Hanley

1 reference

1 December 2017

Ravi Retnakaran

1

1 reference

1 December 2017

Sandy Shen

series ordinal

2

1 reference

1 December 2017

Vladimir Vuksan

series ordinal

4

1 reference

1 December 2017

Jill K Hamilton

series ordinal

5

1 reference

1 December 2017

language of work or name

1 reference

12 June 2008

1 reference

1 December 2017

1 reference

1 December 2017

volume

16

1 reference

1 December 2017

issue

8

1 reference

1 December 2017

page(s)

1901-1907

1 reference

The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Accurate assessment of beta-cell function: the hyperbolic correction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Insulin sensitivity by oral glucose minimal models: validation against clamp

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Dilution of the 75-g oral glucose tolerance test improves overall tolerability but not reproducibility in subjects with different body compositions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Preventing type 2 diabetes using combination therapy: design and methods of the CAnadian Normoglycaemia Outcomes Evaluation (CANOE) trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Impact of differences in fasting glucose and glucose tolerance on the hyperbolic relationship between insulin sensitivity and insulin responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Population approaches to estimate minimal model indexes of insulin sensitivity and glucose effectiveness using full and reduced sampling schedules.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Fitting straight lines when both variables are subject to error

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Statistical data analysis in the computer age.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Methods for clinical assessment of insulin sensitivity and beta-cell function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Insulin sensitivity and beta-cell function in women with polycystic ovary syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed type II diabetes: the Insulin Resistance Atherosclerosis Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Within-subject variability of measures of beta cell function derived from a 2 h OGTT: implications for research studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.307

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2008.307

1 reference

1 December 2017

1 reference